Vitamin D Deficiency among HIV Type 1-Infected Individuals in the Netherlands: Effects of Antiretroviral Therapy

被引:129
|
作者
Van Den Bout-Van Den Beukel, Carolien J. P.
Fievez, Lydia
Michels, Meta
Sweep, Fred C. G. J.
Hermus, Ad R. M. M.
Bosch, Marjolein E. W.
Burger, David M.
Bravenboer, Bert [2 ]
Koopmans, Peter P.
Van Der Ven, Andre J. A. M. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Gen Internal Med, NUCI Int Hlth, NL-6500 HB Nijmegen, Netherlands
[2] Catharina Hosp, Dept Gen Internal Med, Eindhoven, Netherlands
关键词
D O I
10.1089/aid.2008.0058
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vitamin D regulates bone metabolism but has also immunoregulatory properties. In HIV-infected patients bone disorders are increasingly observed. Furthermore, low 1,25(OH)(2)D-3 levels have been associated with low CD4+ counts, immunological hyperactivity, and AIDS progression rates. Few studies have examined the vitamin D status in HIV-infected patients. This study will specifically focus on the effects of antiretroviral agents on vitamin D status. Furthermore, the effect of vitamin D status on CD4 cell recovery after initiation of HAART will be evaluated. Among 252 included patients the prevalence of vitamin D deficiency (<35 nmol/liter from April to September and <25 nmol/liter from October to March) was 29%. Female sex, younger age, dark skin, and NNRTI treatment were significant risk factors in univariate analysis, although in multivariate analyses skin pigmentation remained the only independent risk factor. Median 25(OH)D-3 levels were significantly lower in white NNRTI-treated patients [54.5(27.9-73.8) nmol/liter] compared to white PI-treated patients [77.3 (46.6-100.0) nmol/liter, p = 0.007], while among nonwhites no difference was observed. Both PI-and NNRTI-treated patients had significantly higher blood PTH levels than patients without treatment. Moreover, NNRTI treatment puts patients at risk of elevated PTH levels (>6.5 pmol/liter). Linear regression analysis showed that vitamin D status did not affect CD4 cell recovery after initiation of HAART. In conclusion, 29% of the HIV-1-infected patients had vitamin D deficiency, with skin color as an independent risk factor. NNRTI treatment may add more risk for vitamin D deficiency. Both PI-and NNRTI-treated patients showed higher PTH levels and might therefore be at risk of bone problems. Evaluation of 25( OH) D3 and PTH levels, especially in NNRTI-treated and dark skinned HIV-1-infected patients, is necessary to detect and treat vitamin D deficiency early.
引用
收藏
页码:1375 / 1382
页数:8
相关论文
共 50 条
  • [21] HIV type 1 tat gene heteroduplex mobility assay as a tool to establish epidemiologic relationships among HIV type 1-infected individuals
    Diaz, RS
    de Oliveira, CF
    Pardini, R
    Operskalski, E
    Mayer, AJ
    Busch, MP
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (13) : 1151 - 1156
  • [22] Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients
    Childs, Kathryn
    Welz, Tanya
    Samarawickrama, Amanda
    Post, Frank A.
    [J]. AIDS, 2012, 26 (03) : 253 - 262
  • [23] Association of Functional Impairment with Inflammation and Immune Activation in HIV Type 1-Infected Adults Receiving Effective Antiretroviral Therapy
    Erlandson, Kristine M.
    Allshouse, Amanda A.
    Jankowski, Catherine M.
    Lee, Eric J.
    Rufner, Kevin M.
    Palmer, Brent E.
    Wilson, Cara C.
    MaWhinney, Samantha
    Kohrt, Wendy M.
    Campbell, Thomas B.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (02): : 249 - 259
  • [24] Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study
    Calza, Leonardo
    di Pietro, Giulia
    Colangeli, Vincenzo
    Borderi, Marco
    Zaghi, Irene
    Malosso, Pietro
    Bon, Isabella
    Re, Maria Carla
    Viale, Pierluigi
    [J]. NEW MICROBIOLOGICA, 2019, 42 (03): : 145 - 149
  • [25] Immunological Recovery and Metabolic Disorders in Severe Immunodeficiency HIV Type 1-Infected Children on Highly Active Antiretroviral Therapy
    Resino, Salvador
    Micheloud, Dariela
    Larru, Beatriz
    Bellon, Jose M.
    Leon, Juan Antonio
    Resino, Rosa
    De Jose, M. Isabel
    Gurbindo Gutierrez, M. Dolores
    Mellado, M. Jose
    Guillen, Sara
    Ramos, Jose Tomas
    Munoz-Fernandez, M. Angeles
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 (12) : 1477 - 1484
  • [26] High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs
    Allavena, C.
    Delpierre, C.
    Cuzin, L.
    Rey, D.
    Viget, N.
    Bernard, J.
    Guillot, P.
    Duvivier, C.
    Billaud, E.
    Raffi, F.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (09) : 2222 - 2230
  • [27] Profile of HIV Type 1 Infection and Genotypic Resistance Mutations to Antiretroviral Drugs in Treatment-Naive HIV Type 1-Infected Individuals in Hai Phong, Viet Nam
    Ishizaki, Azumi
    Cuong, Nguyen Hung
    Pham Van Thuc
    Nguyen Vu Trung
    Saijoh, Kiyofumi
    Kageyama, Seiji
    Ishigaki, Kyoko
    Tanuma, Junko
    Oka, Shinichi
    Ichimura, Hiroshi
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (02) : 175 - 182
  • [28] Dietary Intervention Prevents Dyslipidemia Associated With Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Individuals
    Lazzaretti, Rosmeri K.
    Kuhmmer, Regina
    Sprinz, Eduardo
    Polanczyk, Carisi A.
    Ribeiro, Jorge P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (11) : 979 - 988
  • [29] Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study
    Elzi, Luigia
    Conen, Anna
    Patzen, Annalea
    Fehr, Jan
    Cavassini, Matthias
    Calmy, Alexandra
    Schmid, Patrick
    Bernasconi, Enos
    Furrer, Hansjakob
    Battegay, Manuel
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (01):
  • [30] Screening for antiretroviral drug resistance among treatment-naive human immunodeficiency virus type 1-infected individuals in Lebanon
    Mokhbat, Jacques M.
    Melhem, Nada M.
    El-Khatib, Ziad
    Zalloua, Pierre
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2014, 8 (03): : 339 - 348